Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIb Study of Recombinant ALVAC(2)-NY-ESO-1 (M)/TRICOM in Combination With INCB024360 for Patients in Remission With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma Whose Tumors Express NY-ESO-1 or LAGE-1 Antigen

NCT01982487 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT01982487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01982487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIb Study of Recombinant ALVAC(2)-NY-ESO-1 (M)/TRICOM in Combination With INCB024360 for Patients in Remission With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma Whose Tumors Express NY-ESO-1 or LAGE-1 Antigen
Lead sponsor
Roswell Park Cancer Institute
Phase
Phase 1/2
Overall status
Withdrawn
Start date
December 31, 2013
Completion date
Not reported
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent fallopian tube cancer, recurrent ovarian epithelial cancer, recurrent primary peritoneal cavity cancer, stage ia fallopian tube cancer, stage ia ovarian epithelial cancer, stage ia primary peritoneal cavity cancer, stage ib fallopian tube cancer, stage ib ovarian epithelial cancer, stage ib primary peritoneal cavity cancer, stage ic fallopian tube cancer, stage ic ovarian epithelial cancer, stage ic primary peritoneal cavity cancer, stage iia fallopian tube cancer, stage iia ovarian epithelial cancer, stage iia primary peritoneal cavity cancer, stage iib fallopian tube cancer, stage iib ovarian epithelial cancer, stage iib primary peritoneal cavity cancer, stage iic fallopian tube cancer, stage iic ovarian epithelial cancer, stage iic primary peritoneal cavity cancer, stage iiia fallopian tube cancer, stage iiia ovarian epithelial cancer, stage iiia primary peritoneal cavity cancer, stage iiib fallopian tube cancer, stage iiib ovarian epithelial cancer, stage iiib primary peritoneal cavity cancer, stage iiic fallopian tube cancer, stage iiic ovarian epithelial cancer, stage iiic primary peritoneal cavity cancer, stage iv fallopian tube cancer, stage iv ovarian epithelial cancer, stage iv primary peritoneal cavity cancer